MeVis Medical Solutions AG
Research MeVis Medical Solutions AG (M3V) on Bullrun: market cap EUR 43.32M, P/E 56.7, dividend yield 4.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerM3V
- ExchangeXETRA
- CountryGermany
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyEUR
- Market capEUR 43.32M
- P/E56.7
- Dividend yield4.0%
- Financial periodFY2025
- RevenueEUR 16.06M
- Revenue growth-5.4%
- Net incomeEUR 3.17M
- Free cash flowEUR 3.74M
- Gross margin97.7%
Valuation Snapshot
latest market cap is EUR 43.32M; P/E is 56.7; dividend yield is 4.0%.
Peer valuation comparison
Latest P/E is 56.67x versus a Healthcare sector median of 24.46x (131.7% above).
Latest dividend yield is 3.99% versus a Healthcare sector median of 2.11% (89.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 16.06M | EUR 3.17M | EUR 3.74M | 97.7% | 1.74 | EUR 6.52M | n/a | EUR 17.83M |
| FY2024 | EUR 16.97M | EUR 4.56M | EUR 2.84M | 97.1% | 2.51 | EUR 6.53M | n/a | EUR 17.83M |
| FY2023 | EUR 17.34M | EUR 4.92M | EUR 5.77M | 97.4% | 0 | EUR 7.74M | n/a | EUR 17.83M |
| FY2022 | EUR 18.76M | EUR 7.79M | EUR 4.72M | 96.0% | 4.28 | EUR 9.32M | n/a | EUR 17.83M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | EUR 43.32M | 56.7 | 4.0% | 0.95 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.95 EUR, yield 4.0%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.95 EUR |
| FY2024 | 0.95 EUR |
About MeVis Medical Solutions AG
MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is MeVis Medical Solutions AG's market cap?
MeVis Medical Solutions AG's market capitalization is EUR 43.32M.
What is MeVis Medical Solutions AG's P/E ratio?
MeVis Medical Solutions AG's price-to-earnings (P/E) ratio is 56.7.
Does MeVis Medical Solutions AG pay a dividend?
MeVis Medical Solutions AG has a dividend yield of 4.0%.
What does MeVis Medical Solutions AG do?
MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases.